Living Engineered Bacterial Therapeutics: Emerging Affordable Precision Interventions

被引:1
|
作者
Srivastava, Rajkamal [1 ,2 ]
Lesser, Cammie F. [1 ,2 ,3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Ctr Bacterial Pathogenesis, Dept Med, Div Infect Dis, Boston, MA 02114 USA
[2] Harvard Med Sch, Blavatnik Inst, Dept Microbiol, Boston, MA 02115 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[4] Ragon Inst Harvard & MIT, Cambridge, MA 02139 USA
来源
MICROBIAL BIOTECHNOLOGY | 2024年 / 17卷 / 11期
基金
美国国家卫生研究院;
关键词
engineered bacteria; live biotherapeutic products; smart microbes; COLI NISSLE 1917;
D O I
10.1111/1751-7915.70057
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Live biotherapeutic products (LBPs), including engineered bacteria, are rapidly emerging as potential therapeutic interventions. These innovative therapies can serve as live in situ drug delivery platforms for the direct deposition of therapeutic payloads, including complex biologics, at sites of disease. This approach offers a platform likely to enhance therapeutic efficacy and decrease off-target side effects. LBPs also can likely be distributed at a relatively low price point, as their production can be economically scaled up. LBPs represent an exciting new means for ensuring healthy lives and promoting well-being for all ages, aligning with the World Health Organization's sustainable development goal 3.
引用
收藏
页数:8
相关论文
共 46 条
  • [41] Increasing bacterial cellulose compression resilience with glycerol or PEG400 for robuster engineered living materials.
    Caro-Astorga, Joaquin
    Lee, Koon-Yang
    Ellis, Tom
    CARBOHYDRATE POLYMER TECHNOLOGIES AND APPLICATIONS, 2022, 4
  • [42] Combining forces: Integrating engineered bacterial therapeutics with targeted therapies for advanced-stage non-small cell lung cancer
    Deb, Dhruba
    Danina, Tal
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [43] Precision-engineered bacterial nanovectors for synergetic co-delivery to harness cellular senescence and immunomodulation for enhanced tumor eradication
    Ye, Zixuan
    Zhou, Yuanzhuo
    Liang, Lizhen
    Zhao, Jiahui
    Liu, Wenzheng
    Meng, Lingtong
    Huang, He
    Yang, Jingpeng
    Lin, Xinping
    Li, Yanan
    CHEMICAL ENGINEERING JOURNAL, 2025, 505
  • [44] HIV transmission risk behaviors of men and women living with HIV-AIDS: Prevalence, predictors, and emerging clinical interventions
    Kalichman, SC
    CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE, 2000, 7 (01) : 32 - 47
  • [45] Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
    Nayak, Vinayak
    Patra, Sushmita
    Singh, Kshitij R. B.
    Ganguly, Bristy
    Kumar, Das Nishant
    Panda, Deepak
    Maurya, Ganesh Kumar
    Singh, Jay
    Majhi, Sanatan
    Sharma, Rohit
    Pandey, Shyam S.
    Singh, Ravindra Pratap
    Kerry, Rout George
    ENVIRONMENTAL RESEARCH, 2023, 235
  • [46] USE OF LOW LIGHT IMAGE MICROSCOPY TO MONITOR GENETICALLY ENGINEERED BACTERIAL LUCIFERASE GENE-EXPRESSION IN LIVING CELLS AND GENE ACTIVATION THROUGHOUT THE DEVELOPMENT OF A TRANSGENIC ORGANISM
    LANGRIDGE, WHR
    ESCHER, A
    BAGA, M
    OKANE, D
    WAMPLER, J
    KONCZ, C
    SCHELL, J
    SZALAY, AA
    NEW METHODS IN MICROSCOPY AND LOW LIGHT IMAGING, 1989, 1161 : 216 - 229